Need Help? Call 1­-866-­796-­7386
« back to stock screener

  LGND stock: Ligand Pharmaceuticals Inc.

Current Rating
Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$113.44
Market Cap
2.33B
Sector
Health Care
Div. Growth
-
P/E
-
P/B
6.81
P/S
21.32
Dividend %
-
P/CF
-
P/FCF
56.7
Op. Cash Flow
63K
FCF
1.9
Op. Margin
40.20%
Net Margin
-1.50%
ROE
-0.50%
ROI
5.70%
ROA
-0.30%
EPS Growth
-100.70%
Current Ratio
0.7
Debt/Equity
8.70%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Pernix Therapeutics Holdings I (PTX) $4.41 - - 41.2M Strong Buy
Valeant Pharmaceuticals Intl I (VRX) $13.45 - - 3.19B Strong Buy
PhotoMedex Inc (PHMD) $1.35 - - 5.8M Strong Buy
Chembio Diagnostics Inc (CEMI) $6.70 - - 76.3M Strong Buy
Biostar Pharmaceuticals Inc (BSPM) $1.65 - - 4.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More